Clinical trials showcased its efficacy in not just regulating blood sugar but also in aiding substantial weight reduction
Personalized Treatment Plan Finally, we set clear expectations for the treatment timeline and when dosages may increase
Significantly higher price point
modest improvements in LDL and HDL ratios Liver health: Significant improvements in non-alcoholic fatty liver disease (NAFLD), an increasingly common obesity-related condition Sleep apnea: The SURMOUNT-OSA trial showed tirzepatide reduced sleep apnea severity by up to 63% Joint health: Weight reduction directly reduces mechanical load on hips, knees, and ankles reducing pain and improving mobility Ready to Find Out If GLP-1 Medication Is Right for You
Risk varies: Prior stones, diet, and fluid intake matter greatly
For 78-year-old California resident Gloria Dralla, who said she's lost some 40 pounds after buying lower-cost Wegovy in Europe, the Bridge program means being able to continue a treatment that has improved her life